4.5 Article

Depression, anxiety, and prevalent diabetes in the Chinese population: Findings from the China Kadoorie Biobank of 0.5 million people

Journal

JOURNAL OF PSYCHOSOMATIC RESEARCH
Volume 75, Issue 6, Pages 511-517

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jpsychores.2013.09.008

Keywords

Anxiety; Culture; Depression; Epidemiology; Type 2 diabetes

Categories

Funding

  1. Kadoorie Charitable Foundation in Hong Kong
  2. Wellcome Trust in the UK [088158/Z/09/Z]
  3. Chinese Ministry of Science and Technology [2011BAI09B01]
  4. UK Medical Research Council
  5. British Heart Foundation
  6. Cancer Research UK
  7. National Institute of Health [K01-MH093642-A1, R21-DK8356430-A1]
  8. National Natural Science Foundation of China [81202266]
  9. Sino-British Friendship Fellowship scheme
  10. MRC [MC_U137686851] Funding Source: UKRI
  11. Medical Research Council [MC_U137686851] Funding Source: researchfish

Ask authors/readers for more resources

Objective: Despite previous investigation, uncertainty remains about the nature of the associations of major depression (MD) with type 2 diabetes mellitus (T2DM), particularly in adult Chinese, and the relevance of generalized anxiety disorder (GAD) for T2DM. Methods: Cross-sectional data from the China Kadoorie Biobank Study, a sample of approximately 500,000 adults from 10 geographically defined regions of China, were analyzed. Past year MD and GAD were assessed using the Composite International Diagnostic Inventory. T2DM was defined as either having self-reported physician diagnosis of diabetes at age 30 or later (clinically-identified cases) or having a non-fasting blood glucose >= 11.1 mmol/L or fasting blood glucose >= 7.0 mmol/L but no prior diagnosis of diabetes (screen-detected cases). Logistic regression was used to assess the relationship between MD and GAD with clinically-identified and screen-detected T2DM, adjusting for demographic characteristics and health behaviors. Results: The prevalence of T2DM was 53% (3.2% clinically-identified and 2.1% screen-detected). MD was significantly associated with clinically-identified T2DM (odds ratio [OR]: 1.75,95% confidence interval (CI): 1.47-2.08), but not with screen-detected T2DM (OR: 1.18,95% CI: 0.92-1.51). GAD was associated with clinically-identified (OR: 2.14,95% CI: 1.60-2.88) and modestly associated with screen-detected (OR: 1.44,95% CI: 0.99-2.08) T2DM. The relationship between MD and GAD with T2DM was moderated by obesity. Conclusion: MD is associated with clinically-identified, but not screen-detected T2DM. GAD is associated with both clinically-identified and screen-detected T2DM. The relationship between MD and T2DM is strongest among those who are not obese. (c) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available